US Patent Issued to EIT Pharma on Dec. 30 for "Treatment of hepatitis delta virus infection with interferon lambda" (California Inventor)

ALEXANDRIA, Va., Dec. 31 -- United States Patent no. 12,508,297, issued on Dec. 30, was assigned to EIT Pharma Inc. (Los Angeles).

"Treatment of hepatitis delta virus infection with interferon lambda" was invented by Eduardo Bruno Martins (Palo Alto, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods of treating a hepatitis delta virus (HDV) infection in a human patient are provided. In some embodiments, the method comprising administering to the patient a therapeutically effective amount of interferon lambda for at least four weeks."

The patent was filed on Feb. 18, 2021, under Application No. 17/178,424.

*For further information, including images, charts and tables, please visit: http://patft....